261 related articles for article (PubMed ID: 37923864)
1. Treatment of systemic juvenile idiopathic arthritis.
Hinze CH; Foell D; Kessel C
Nat Rev Rheumatol; 2023 Dec; 19(12):778-789. PubMed ID: 37923864
[TBL] [Abstract][Full Text] [Related]
2. Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives.
Ambler WG; Nanda K; Onel KB; Shenoi S
Ann Med; 2022 Dec; 54(1):1839-1850. PubMed ID: 35786149
[TBL] [Abstract][Full Text] [Related]
3. Improvement of Refractory Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease with Single-Agent Blockade of IL-1β and IL-18.
Rood JE; Rezk A; Pogoriler J; Finn LS; Burnham JM; Josephson MB; Bar-Or A; Behrens EM; Canna SW
J Clin Immunol; 2023 Jan; 43(1):101-108. PubMed ID: 36006569
[TBL] [Abstract][Full Text] [Related]
4. The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives.
Toplak N; Blazina Š; Avčin T
Drug Des Devel Ther; 2018; 12():1633-1643. PubMed ID: 29922038
[TBL] [Abstract][Full Text] [Related]
5. Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors.
Schulert GS; Yasin S; Carey B; Chalk C; Do T; Schapiro AH; Husami A; Watts A; Brunner HI; Huggins J; Mellins ED; Morgan EM; Ting T; Trapnell BC; Wikenheiser-Brokamp KA; Towe C; Grom AA
Arthritis Rheumatol; 2019 Nov; 71(11):1943-1954. PubMed ID: 31379071
[TBL] [Abstract][Full Text] [Related]
6. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
[TBL] [Abstract][Full Text] [Related]
7. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Lee PY; Schulert GS; Canna SW; Huang Y; Sundel J; Li Y; Hoyt KJ; Blaustein RB; Wactor A; Do T; Halyabar O; Chang MH; Dedeoglu F; Case SM; Meidan E; Lo MS; Sundel RP; Richardson ET; Newburger JW; Hershfield MS; Son MB; Henderson LA; Nigrovic PA
Ann Rheum Dis; 2020 Feb; 79(2):225-231. PubMed ID: 31707357
[TBL] [Abstract][Full Text] [Related]
8. Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis.
Chen G; Deutsch GH; Schulert GS; Zheng H; Jang S; Trapnell B; Lee PY; Macaubas C; Ho K; Schneider C; Saper VE; de Jesus AA; Krasnow MA; Grom A; Goldbach-Mansky R; Khatri P; Mellins ED; Canna SW
Arthritis Rheumatol; 2022 Jul; 74(7):1271-1283. PubMed ID: 35189047
[TBL] [Abstract][Full Text] [Related]
9. Systemic juvenile idiopathic arthritis and macrophage activation syndrome: update on pathogenesis and treatment.
Yasin S; Schulert GS
Curr Opin Rheumatol; 2018 Sep; 30(5):514-520. PubMed ID: 29870499
[TBL] [Abstract][Full Text] [Related]
10. Emergent high fatality lung disease in systemic juvenile arthritis.
Saper VE; Chen G; Deutsch GH; Guillerman RP; Birgmeier J; Jagadeesh K; Canna S; Schulert G; Deterding R; Xu J; Leung AN; Bouzoubaa L; Abulaban K; Baszis K; Behrens EM; Birmingham J; Casey A; Cidon M; Cron RQ; De A; De Benedetti F; Ferguson I; Fishman MP; Goodman SI; Graham TB; Grom AA; Haines K; Hazen M; Henderson LA; Ho A; Ibarra M; Inman CJ; Jerath R; Khawaja K; Kingsbury DJ; Klein-Gitelman M; Lai K; Lapidus S; Lin C; Lin J; Liptzin DR; Milojevic D; Mombourquette J; Onel K; Ozen S; Perez M; Phillippi K; Prahalad S; Radhakrishna S; Reinhardt A; Riskalla M; Rosenwasser N; Roth J; Schneider R; Schonenberg-Meinema D; Shenoi S; Smith JA; Sönmez HE; Stoll ML; Towe C; Vargas SO; Vehe RK; Young LR; Yang J; Desai T; Balise R; Lu Y; Tian L; Bejerano G; Davis MM; Khatri P; Mellins ED;
Ann Rheum Dis; 2019 Dec; 78(12):1722-1731. PubMed ID: 31562126
[TBL] [Abstract][Full Text] [Related]
11. Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies.
Efthimiou P; Kontzias A; Hur P; Rodha K; Ramakrishna GS; Nakasato P
Semin Arthritis Rheum; 2021 Aug; 51(4):858-874. PubMed ID: 34175791
[TBL] [Abstract][Full Text] [Related]
12. Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Bracaglia C; de Graaf K; Pires Marafon D; Guilhot F; Ferlin W; Prencipe G; Caiello I; Davì S; Schulert G; Ravelli A; Grom AA; de Min C; De Benedetti F
Ann Rheum Dis; 2017 Jan; 76(1):166-172. PubMed ID: 27296321
[TBL] [Abstract][Full Text] [Related]
13. Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany.
Hinze CH; Holzinger D; Lainka E; Haas JP; Speth F; Kallinich T; Rieber N; Hufnagel M; Jansson AF; Hedrich C; Winowski H; Berger T; Foeldvari I; Ganser G; Hospach A; Huppertz HI; Mönkemöller K; Neudorf U; Weißbarth-Riedel E; Wittkowski H; Horneff G; Foell D;
Pediatr Rheumatol Online J; 2018 Jan; 16(1):7. PubMed ID: 29357887
[TBL] [Abstract][Full Text] [Related]
14. Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Boom V; Anton J; Lahdenne P; Quartier P; Ravelli A; Wulffraat NM; Vastert SJ
Pediatr Rheumatol Online J; 2015 Dec; 13():55. PubMed ID: 26634252
[TBL] [Abstract][Full Text] [Related]
15. Interfering with interferons: targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA).
Verweyen EL; Schulert GS
Rheumatology (Oxford); 2022 Mar; 61(3):926-935. PubMed ID: 34459891
[TBL] [Abstract][Full Text] [Related]
16. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China.
Zou LX; Zhu Y; Sun L; Ma HH; Yang SR; Zeng HS; Xiao JH; Yu HG; Guo L; Xu YP; Lu MP
World J Pediatr; 2020 Feb; 16(1):89-98. PubMed ID: 31612427
[TBL] [Abstract][Full Text] [Related]
17. Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease.
Huang Y; Sompii-Montgomery L; Patti J; Pickering A; Yasin S; Do T; Baker E; Gao D; Abdul-Aziz R; Behrens EM; Canna S; Clark M; Co DO; Collins KP; Eberhard B; Friedman M; Graham TB; Hahn T; Hersh AO; Hobday P; Holland MJ; Huggins J; Lu PY; Mannion ML; Manos CK; Neely J; Onel K; Orandi AB; Ramirez A; Reinhardt A; Riskalla M; Santiago L; Stoll ML; Ting T; Grom AA; Towe C; Schulert GS
Arthritis Care Res (Hoboken); 2024 Mar; 76(3):328-339. PubMed ID: 37691306
[TBL] [Abstract][Full Text] [Related]
18. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
Arduini A; Marasco E; Marucci G; Pardeo M; Insalaco A; Caiello I; Moneta GM; Prencipe G; De Benedetti F; Bracaglia C
Pediatr Rheumatol Online J; 2019 May; 17(1):25. PubMed ID: 31118063
[TBL] [Abstract][Full Text] [Related]
19. Systemic onset juvenile idiopathic arthritis: a single center experience.
Sağ E; Uzunoğlu B; Bal F; Sönmez HE; Demir S; Bilginer Y; Özen S
Turk J Pediatr; 2019; 61(6):852-858. PubMed ID: 32134578
[TBL] [Abstract][Full Text] [Related]
20. Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome.
Inoue N; Schulert GS
Arthritis Res Ther; 2023 Mar; 25(1):48. PubMed ID: 36964620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
